drugset / Trial / NCT07140614
A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A.
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to characterize the safety, tolerability, and pharmacokinetics of EDK060 as compared to placebo in adult patients with CMT1A.
Timeline
- Start
- 2025-09-30
- Primary completion
- 2028-02-25
- Completion
- 2028-02-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EDK060 | Unknown | — | Intravenous |